Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion type Assertion NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_head.
- NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion description "[In this study, BLyS levels were measured before and after 4 weekly doses of rituximab in 30 patients with previously untreated follicular Grade 1 NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_provenance.
- NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion evidence source_evidence_literature NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_provenance.
- NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion SIO_000772 19051265 NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_provenance.
- NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion wasDerivedFrom befree-20150227 NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_provenance.
- NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_assertion wasGeneratedBy ECO_0000203 NP851269.RAV0vkNWgr3QgwJ2byxp9xOoe9vGn0UJWjAlMkUCIX2uk130_provenance.